NTR
Nutrien Ltd
$66.93
▲ 0.4%Updated Today 3:42 PM ET
NTR at a glance — five pillars scored 0–100 from real filed financials.
Overall: Favorable · 63/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 7.7% over the last 12 months
Market Cap
$32.21B
P/E
13.05x
Forward P/E (est.)
9.32x
ROE
9.5%
Revenue Growth
8.4%
EPS Growth
360.8%
Profit Margin
8.6%
FCF Yield
18.3%
Debt / Equity
0.47x
ROIC
9.0%
Interest Coverage
5.01x
Current Ratio
1.34x
Dividend Yield
3.4%
Implied Growth (rev. DCF)
2.3%
Rating Score
63/100
Nutrien Ltd (NTR) is a large-cap company in the Chemicals industry, part of the Materials sector of the S&P 500, with a market value around $32.21B.
In its latest reported year it generated about $26.89B in revenue and $2.30B in net profit.
Our model rates NTR Favorable (63/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (9 years of history).
The numbers don't show a durable competitive advantage — margins, growth, or returns on capital have been unstable or thin. Great returns are still possible; they just aren't protected.
29.7% average over the last 3 years
±6.5 pts around 28.8% across 9 years
grew in 6 of the last 8 year-over-year periods
positive in 9 of 9 years
9.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what NTR's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. NTR trades near $66.93, around its 50-day average ($68.46) and 200-day average ($66.10). Price tangled in its moving averages means there is no clear trend — the stock is ranging.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 38 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. NTR's is $1.53 (~2.3% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month NTR found buyers near $59.72 (support) and sellers near $69.00 (resistance); its 52-week range is $53.03–$85.36. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.3× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
-0.8%
Revenue moved from $4.55B in 2017 to $26.89B in 2025, a 24.9% compound annual growth rate. The most recent year grew a steady 8.4% year over year. Slower, mature growth is common for established businesses.
Gross Margin
31.0%
Operating Margin
13.9%
Net Margin
8.5%
ROE
9.5%
Nutrien Ltd keeps about 8.6% of each sales dollar as net profit, with a 31.0% gross margin and 13.9% operating margin. Return on equity is 9.5% and return on invested capital about 9.0%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$9.35B
Net Debt
$8.65B
Net Debt / EBITDA
2.32x
Debt / Equity
0.47x
Leverage: debt-to-equity is 0.5x, and operating profit covers interest about 5.0x, with a current ratio of 1.3x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $9.35B of total debt against $701.00M of cash.
Operating CF
$4.01B
Free Cash Flow
$2.13B
FCF Margin
7.9%
In the latest year Nutrien Ltd produced about $4.01B of operating cash flow and $2.13B of free cash flow after capital spending. That is a free-cash-flow yield of about 18.3% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The payout is comfortably covered by cash the business actually generates, with a raise habit behind it.
Dividend yield
3.4%
Per share (latest FY)
$2.16
Total paid (latest FY)
$1.06B
History on record
9 years
dividend uses 50% of free cash flow
46% of net income paid out
total dividends increased 3 years in a row
no cuts in the last 9 years on record
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
13.05x
P/S
1.16x
P/B
1.15x
EV / EBITDA
6.69x
NTR trades at 13.1x trailing earnings (about 9.3x on estimated forward earnings), 1.2x sales, and 1.2x book value. Reverse-engineering today's price implies the market expects roughly 2.3% long-term free-cash-flow growth. That is an undemanding multiple — potentially cheap if the business is stable.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$81.89
Current price
$66.93
Starting FCF (latest 10-K)
$2.13B
Growth, years 1–5
8.4%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where NTR sits versus its Materials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 54 Materials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How NTR stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
In the Materials sector (78 S&P 500 companies), NTR ranks #21 of 78 by our overall rating. It trades at a discount versus the sector on earnings (13.1x P/E vs. 21.2x median) with a lower return on equity (9.5% vs. 16.1%) and faster revenue growth (8.4% vs. 7.9%).
P/E vs sector
13.1x
median 21.2x
ROE vs sector
9.5%
median 16.1%
Growth vs sector
8.4%
median 7.9%
Sector rank
#21
of 78 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Materials companies by sub-industry and size. Sector median is across all 78 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $66.93 today · expected CAGR -2% – 7%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $29.04B | $31.36B | $33.87B | $36.58B | $39.50B |
| Net income | $2.61B | $2.82B | $3.05B | $3.29B | $3.56B |
| EPS | $5.43 | $5.86 | $6.33 | $6.84 | $7.39 |
| Share price (low) | $43.44 | $46.92 | $50.67 | $54.72 | $59.10 |
| Share price (high) | $70.59 | $76.24 | $82.34 | $88.92 | $96.04 |
| CAGR (low–high) | -35% / 5% | -16% / 7% | -9% / 7% | -5% / 7% | -2% / 7% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for NTR:
- Healthy free-cash-flow yield (~18.3%) funds buybacks and dividends.
- A conservative balance sheet (debt/equity 0.5x) lowers risk.
- Pays a 3.4% dividend on top of any price gains.
- Our model's overall read is Favorable (63/100).
The case against NTR:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen favourably: Nutrien Ltd is a large-cap materials business growing at a mature pace, with modest profitability, and a sound balance sheet. It trades at 13.1x earnings, which our model scores Favorable (63/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 26 Wall Street analysts covering NTR recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more positive over the last three months (+10 pts of buy ratings).
Latest SEC Filings
NTR's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
In the Idea Lab
NTR — frequently asked questions
Is NTR a good stock to buy?
We don't give buy or sell advice. Our model rates Nutrien Ltd Favorable (63/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is NTR's rating on The Stocks School?
Nutrien Ltd currently scores 63/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does NTR's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Nutrien Ltd's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for NTR calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this NTR analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell NTR. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.